RDNVs reverse osteoporosis by potentiating osteogenic differentiation of hBMSCs via targeting estrogen receptor A (ERA) signaling
Schematic illustration of RDNVs reverse osteoporosis by potentiating osteogenic differentiation of hBMSCs via targeting estrogen receptor α (ERα) signaling. RDNVs, a natural product isolated from fresh Rhizoma Drynariae root juice by differential ultracentrifugation, exhibited potent bone tissue-targeting activity and anti-osteoporosis efficacy in an ovariectomized mouse model. RDNVs, effectively internalized by hBMSCs, enhanced proliferation and ERα expression levels of hBMSC, and promoted osteogenic differentiation and bone formation. Mechanistically, via the ERα signaling pathway, RDNVs facilitated mRNA and protein expression of bone morphogenetic protein 2 and runt-related transcription factor 2 in hBMSCs, which are involved in regulating osteogenic differentiation. Further analysis revealed that naringin, existing in RDNVs, was the active component targeting ERα in the osteogenic effect
Publication
Rhizoma Drynariae-derived nanovesicles reverse osteoporosis by potentiating osteogenic differentiation of human bone marrow mesenchymal stem cells via targeting ERα signaling (2024) Qing Zhao, et al. Acta Pharm Sin B. 2024 Feb 10;14(5). Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | PBS | PBS | ncbigene_synonym | TSPO | 706 |
| Homo sapiens | Primates | PBS | PBS | ncbigene_synonym | CHRM3 | 1131 |
| Homo sapiens | Primates | BMP2 | BMP2 | ncbigene_symbol | BMP2 | 650 |
| Homo sapiens | Primates | p-Smad1 | SMAD1 | ncbigene_symbol | SMAD1 | 4086 |
| Homo sapiens | Primates | p-Smad1 | SMAD1 | ncbigene_synonym | GARS1 | 2617 |
| Homo sapiens | Primates | p-Smad1/5/8 | SMAD5 | ncbigene_symbol | SMAD5 | 4090 |
| Homo sapiens | Primates | p-Smad1/5/8 | SMAD8 | ncbigene_synonym | SMAD9 | 4093 |
| Homo sapiens | Primates | Runx2 | RUNX2 | ncbigene_symbol | RUNX2 | 860 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| Naringin | Naringin | (2S)-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside | chebi:28819 | |
| Naringin | Naringin | (2S)-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside | chebi:28819 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|